Seminoma

Common Name(s)

Seminoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Seminoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Seminoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Seminoma" returned 352 free, full-text research articles on human participants. First 3 results:

Primary retroperitoneal seminoma - embryology, histopathology and treatment particularities.
 

Author(s): Constantin Virgil Gîngu, Mihaela Mihai, Cătălin Baston, Mugurel Alexandru Crăsneanu, Alexandru Vladimir Dick, Vlad Olaru, Ioanel Sinescu

Journal: Rom J Morphol Embryol. 2016 ;57(3):1045-1050.

 

Retroperitoneal seminoma is a very rare form of cancer, with embryological origin represented by primordial germ cells from the urogenital ridges left behind during the fetal development. Extragenital germ cell tumors can also occur in the mediastinum or the pineal gland. The aim ...

Last Updated: 21 Dec 2016

Go To URL
Long-term outcomes following post-operative radiotherapy for Stage I/II testicular seminoma - an Australasian single-institution experience.
 

Author(s): Wee Loon Ong, Lester Nazareth, Benjamin Hindson, Bronwyn Matheson, Jeremy L Millar

Journal: J Med Radiat Sci. 2016 Sep;63(3):161-9.

 

The aim of the study is to review the long-term oncological outcomes and adverse effects of post-operative radiotherapy (PORT) for Stage I/II seminoma patients in an Australian radiation treatment centre.

Last Updated: 20 Sep 2016

Go To URL
Primary thymic mediastinal seminoma with florid granulomatous reaction.
 

Author(s): Devika Gupta, Ashutosh Rath, Khushi Ram Rathi, Giriraj Singh

Journal: Indian J Pathol Microbiol. ;59(3):351-4.

 

Primary mediastinal seminomas are rare tumors. Morphologically, they can be associated with secondary changes in the form of thymic remnants, cystic change, epithelioid granulomas, abundant fibrosis, and syncytiotrophoblast like cells. Ours was an interesting case where a 17-year-old ...

Last Updated: 11 Aug 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Seminoma" returned 37 free, full-text review articles on human participants. First 3 results:

Adjuvant treatment for Stage I seminoma: Why radiotherapy is better than carboplatin.
 

Author(s): Prahlad H Yathiraj, Krishna Sharan, Donald J Fernandes, M S Vidyasagar

Journal: J Cancer Res Ther. ;12(4):1216-1219.

 

Adjuvant treatment options for Stage I seminoma include active surveillance, chemotherapy, and radiotherapy. Active surveillance may not be ideal for the average Indian patient. Of the two accepted adjuvant therapy options, namely single-dose carboplatin chemotherapy and radiotherapy ...

Last Updated: 7 Feb 2017

Go To URL
Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance--protocol for a systematic review.
 

Author(s): Frank Kunath, Annabel Spek, Katrin Jensen, Friedemann Zengerling, Stefanie Schmidt

Journal:

 

Testicular cancer is primarily treated with the surgical removal of the affected testis. About 50% of testicular cancer patients present with a stage I seminoma. If no chemo- or radiotherapy as adjuvant treatment is initiated after orchiectomy, 15-20% of these patients will develop ...

Last Updated: 19 Dec 2015

Go To URL
Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the postchemotherapy management of patients with seminoma: systematic review and meta-analysis.
 

Author(s): Giorgio Treglia, Ramin Sadeghi, Salvatore Annunziata, Carmelo Caldarella, Francesco Bertagna, Luca Giovanella

Journal: Biomed Res Int. 2014 ;2014():852681.

 

To meta-analyze published data about the diagnostic performance of fluorine-18-Fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET) and PET/computed tomography (PET/CT) in the postchemotherapy management of patients with seminoma.

Last Updated: 25 Jun 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Therapy De-escalation in Seminoma Stage IIA/B
 

Status: Recruiting

Condition Summary: Seminoma

 

Last Updated: 10 Apr 2017

Go to URL
Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
 

Status: Recruiting

Condition Summary: Seminoma

 

Last Updated: 8 Jun 2016

Go to URL
Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma
 

Status: Recruiting

Condition Summary: Lymphadenopathy; Stage I Testicular Seminoma; Stage II Testicular Seminoma

 

Last Updated: 14 Jun 2017

Go to URL